XTL Biopharmaceuticals Ltd. (XTLB)
0.59
0.00 (0.00%)
USD |
NASDAQ |
Mar 20, 16:00
0.585
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals EPS Diluted (Quarterly) : -0.0292 for Dec. 31, 2024
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | 0.6002 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.223 |
| Can-Fite BioPharma Ltd. | -- |
| Evogene Ltd. | -0.609 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.257M |
| Revenue (Quarterly) | 0.2913M |
| Total Expenses (Quarterly) | 0.5483M |